Clinical trial
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With…
NCT00262847 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00262847 |
|---|---|
| Title | Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer |
| Official title | A Phase III Trial of Carboplatin and Paclitaxel Plus Placebo Versus Carboplatin and Paclitaxel Plus Concurrent Bevacizumab (NSC # 704865) Followed by Placebo, Versus Carboplatin and Paclitaxel Plus Concurrent and Extended Bevacizumab, in Women With Newly Diagnosed, Previously Untreated, Stage III or… |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | NRG Oncology |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor, Ovarian Clear Cell Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mucinous Adenocarcinoma and 17 more |
| Intervention type | Biological, Drug, Other |
| Interventions | Bevacizumab, Carboplatin, Laboratory Biomarker Analysis, Paclitaxel, Placebo, Quality-of-Life Assessment |
| Enrollment | 1,873 |
| Start date | Sep 1, 2005 |
| Primary completion | Nov 1, 2010 |
| Completion | Apr 1, 2015 |
| First posted | Dec 7, 2005 |
| Last update posted | Jul 23, 2019 |
| Countries | Canada, Japan, South Korea, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: